Suppr超能文献

相似文献

1
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.
World J Gastroenterol. 2014 Mar 21;20(11):3002-10. doi: 10.3748/wjg.v20.i11.3002.
2
Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease.
Adv Biomed Res. 2017 Feb 22;6:12. doi: 10.4103/2277-9175.200787. eCollection 2017.
4
The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial.
Hepatology. 2015 May;61(5):1555-64. doi: 10.1002/hep.27662. Epub 2015 Mar 20.
5
Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation?
Semin Liver Dis. 2019 Nov;39(4):476-482. doi: 10.1055/s-0039-1693114. Epub 2019 Jul 22.
8
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.
J Hepatol. 2021 Sep;75(3):506-513. doi: 10.1016/j.jhep.2021.03.014. Epub 2021 Mar 24.

引用本文的文献

1
Myths and facts about the role of diet in metabolic dysfunction-associated steatotic liver disease.
World J Hepatol. 2025 Aug 27;17(8):107909. doi: 10.4254/wjh.v17.i8.107909.
5
A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia.
J Clin Endocrinol Metab. 2024 May 17;109(6):1540-1549. doi: 10.1210/clinem/dgad749.
6
Secondary Iron Overload and the Liver: A Comprehensive Review.
J Clin Transl Hepatol. 2023 Aug 28;11(4):932-941. doi: 10.14218/JCTH.2022.00420. Epub 2023 Feb 1.
7
Consensus Statement on the definition and classification of metabolic hyperferritinaemia.
Nat Rev Endocrinol. 2023 May;19(5):299-310. doi: 10.1038/s41574-023-00807-6. Epub 2023 Feb 17.
8
Iron as a therapeutic target in chronic liver disease.
World J Gastroenterol. 2023 Jan 28;29(4):616-655. doi: 10.3748/wjg.v29.i4.616.
10
Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.
Front Endocrinol (Lausanne). 2022 Sep 5;13:942412. doi: 10.3389/fendo.2022.942412. eCollection 2022.

本文引用的文献

1
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
J Hepatol. 2013 Sep;59(3):550-6. doi: 10.1016/j.jhep.2013.04.027. Epub 2013 May 9.
2
Dietary iron overload induces visceral adipose tissue insulin resistance.
Am J Pathol. 2013 Jun;182(6):2254-63. doi: 10.1016/j.ajpath.2013.02.019. Epub 2013 Apr 8.
3
Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.
Aliment Pharmacol Ther. 2013 Apr;37(7):720-9. doi: 10.1111/apt.12255. Epub 2013 Feb 26.
4
The burden of liver disease in Europe: a review of available epidemiological data.
J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005.
6
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease.
J Hepatol. 2013 Apr;58(4):771-7. doi: 10.1016/j.jhep.2012.11.031. Epub 2012 Nov 29.
7
The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
PLoS One. 2012;7(11):e48804. doi: 10.1371/journal.pone.0048804. Epub 2012 Nov 5.
8
Adipocyte iron regulates adiponectin and insulin sensitivity.
J Clin Invest. 2012 Oct;122(10):3529-40. doi: 10.1172/JCI44421. Epub 2012 Sep 10.
10
Ferroptosis: an iron-dependent form of nonapoptotic cell death.
Cell. 2012 May 25;149(5):1060-72. doi: 10.1016/j.cell.2012.03.042.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验